TB

Thekkumpuram Bhavadasan Ravi

Active Director Director DIN 09317499
DIN 09317499 First appointment Sep 2021 Primary industry Transportation
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Thekkumpuram Bhavadasan Ravi

Data last updated:

Thekkumpuram Bhavadasan Ravi is a Director at Hermesmeds Private Limited (since 2021). The company operates in Transportation.

DIN 09317499
Primary Designation Director
Industry Transportation
First Appointment 13 Sep 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hermesmeds Private Limited U63030KL2021PTC070884
Director13 Sep 20212021Active

Board colleagues of Thekkumpuram Bhavadasan Ravi

NameDINCompanyDesignation
Thekkumpuram Ravi Vishak09317498Hermesmeds Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Hermesmeds Private Limited
Premium access

Shareholding and investment profile for Thekkumpuram Bhavadasan Ravi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Thekkumpuram Bhavadasan Ravi

Thekkumpuram Bhavadasan Ravi currently holds 1 directorship: Hermesmeds Private Limited (Director, since 13 Sep 2021).

Thekkumpuram Bhavadasan Ravi was first appointed on 13 Sep 2021 as Director at Hermesmeds Private Limited.

The current boards of Thekkumpuram Bhavadasan Ravi's companies include Thekkumpuram Ravi Vishak (Hermesmeds Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available